We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » New Registry Will Track Real-World Efficacy of Approved Alzheimer’s Treatments
New Registry Will Track Real-World Efficacy of Approved Alzheimer’s Treatments
A new national registry, sponsored by the Alzheimer’s Association, will track real-world outcomes data for Alzheimer’s patients receiving FDA-approved treatments for the disease, including the antiamyloid antibody Aduhelm.